The world’s biggest dairy co-operative will review its stake in Chinese formula milk company Beingmate after unveiling the first ever annual loss in its 17-year history.
Direct selling is on the rise in India, with analysts predicting the industry will reach a value of US$8.96bn (Rs645bn) and create almost 20 million jobs in the country by 2025.
Nutraceutical firm ChromaDex will launch its TRU NIAGEN supplement in New Zealand next month via its exclusive distributor, local supplement brand Matakana Superfoods.
Bubs Australia’s current CEO Nicholas Simms has announced his resignation from the infant nutrition firm, with founder, MD and former CEO Kristy Carr to take over her previous duties once more.
In the first of our monthly recaps on the latest APAC brand news, we take a look at the latest developments at BY-HEALTH, Life-Space, Blackmores, Bubs and Bellamy’s.
Infant nutrition firm Bellamy's Organic has announced a 37% year-on-year growth in sales revenue to US$236.1m (A$329m) for the 2018 financial year, up from US$172.3m (A$240m) in 2017.
The debate about what constitutes 'good evidence', always a controversial point, has recently become even more heated, writes complementary medicines consultant Michael Smith.
Indian sports nutrition retail chain Muscle and Strength India has opened its fifth store within just six months of being in business, and is capitalising on its growing popularity to educate consumers.
From an infant formula recall disaster for Danone, to the latest developments in personalised nutrition in Japan, here we reveal the top five stories trending across our social media channels right now.
DSM has again made Fortune magazine's Change the World list, an annual recognition of companies that have had a positive social impact through their core business strategy.
With India's supplements sector targeting US$10bn sales by 2025, five industry experts have outlined how they believe firms can best tap into rising consumer interest in health and wellness.
Blackmores recorded 9% year-on-year revenue growth to A$601.1m for the financial year ending in June, with China and overall Asia sales contributing significantly to this increase.
A new $40m-a-year scheme to grow New Zealand's food and fibre sectors sustainably has been unveiled by agriculture minister Damien O’Connor, who said the nation needed to move from 'volume to value'.
Australian supplement firms should target Chinese millennials if they want to maximise their growth opportunities in the country, the founder and president of the Australia-China SME Association (ACSME) has argued.
Singapore chiropractic centre Elite Spine Centres is employing personalised nutrition to supplement its treatments after partnering with Imagene Labs to provide genetic testing services to its patients.
Australian nutraceutical firm Renovatio has outlined plans for APAC expansion with its apple-based antioxidant products, with South Korea, Thailand and Macau in its sights.
Utah-based network marketing company LifeVantage has reported year end earnings gains and sales increases in all its markets as it starts to fully enter the biggest market of all—Mainland China.
Infant formula firm Ausnutria Dairy has announced a 51.6% year-on-year growth in revenue to RMB2,582.4m for H1 2018, largely attributed to the continuous increase in the sales of its house-brand formula products.
Singapore’s Agri-Food & Veterinary Authority (AVA) has recalled a batch of Dumex Mamil Gold Infant Milk Formula - Step 1 (850g) after detecting cronobacter sakazakii bacteria in samples.
ASX-listed retail firm AuMake International has entered into a supply agreement with New Zealand-based Pure Nutrition to develop an exclusive formula milk range made with A1 and A2 beta-casein proteins for China.
Japan's consumer genetic testing industry is booming, buoying hopes that personalised nutrition firms can tap into demands for tailored products, especially among the elderly.
Wacker is seeking to boost its nutraceutical business in South East Asia by introducing its antioxidant nutraceutical ingredients, CAVACURMIN and HTEssence, for the first time in Malaysia at an exclusive event in Kuala Lumpur.
DSM is pursuing a patent infringement law suit in China against a competitor for alleged misappropriation of intellectual property related to the production of a key ingredient of Biotin, also known as vitamin B7 or vitamin H.
Australian organic infant formula manufacturer Bubs has announced a massive rise of over 500% in sales, thanks largely to the growth in export sales to China.
Australian nutraceutical brand Entity Health is harnessing its patented sublingual wafer technology to develop health supplements that it claims has therapeutic effects.
The Chinese government has retaliated in the latest escalation of President Trump’s trade war by releasing lists of new tariffs on US products, the highest of which will reach 25%. Experts worry that the fallout could affect the supplement industry.
Wattle Health is making significant headway in both India and China, starting with a 12-month deal with Vasudevan and Sons Exim Private (VSEP) for its baby food range.
Australian direct-to-consumer firm Australian NaturalCare is using daigou sales to establish itself in China, thanks to its partnership with Australian company DaigouSales.
Australian firm Nuchev is banking on its signature goat milk formula, Oli6, to develop products for both young children and seniors, spurred by a new study that pointed to the formula's health benefits.
Speak to any industry insider in China and one of the hottest topics is sports nutrition — everyone agrees that the sector is soaring, even if nobody is sure by exactly how much.
Health & Happiness International (H&H, formerly Biostime International) has now launched its $350m dual-currency loan from Goldman Sachs into limited syndication.
South East Asia's fortified food market is at a tipping point where it is ready to progress from fortification with traditional vitamins and minerals, and move towards specialised ingredients such as asataxanthin.
China's 'new retail' phenomenon — whereby companies like Alibaba seek to converge e-commerce insights with bricks-and-mortar retail operations — could provide as many opportunities for supplement brands as it has done for food firms, Blackmores...
Yashili has announced deals in China and New Zealand to strengthen supply and service agreements with two of its biggest shareholders, Mengniu and Danone, while also bolstering its relationship with Australia's Burra Foods.
China's supplement market will continue to experience double-digit annual growth for the next couple of years, but longer-term success hinges on regulatory reform, says the executive director of Health Products Association – China.
Health & Happiness International (H&H, formerly Biostime International) — and owner of Swisse — has announced it is seeking a loan of up to US$350m through Goldman Sachs.
With one billion users and accounting for 35% of Chinese consumers' time spent on mobile devices, supplement brands trying to break into China can ill-afford to ignore WeChat...but how do they start to shape a successful strategy on the platform?
Seniors in APAC have redefined ageing, and industry must adapt to this change or risk alienating its largest and most affluent group of consumers, according to DuPont's ASEAN marketing leader, Michelle Lee.
OmniActive Health Technologies believes its recent Good Manufacturing Practices (GMP) registration for its Hosur, Tamil Nadu facility is likely to strengthen its bid for APAC expansion.
DSM has underlined personalised nutrition as a major focus under its new strategy, and stated it would continue to seek acquisitions to strengthen its nutrition offerings.
Swisse is harnessing the power of a little-known plant called Andrographis paniculata to relieve symptoms of the common cold and provide immune support.
Chr. Hansen is optimistic it can tap into the benefits of its patented probiotic strain, LGG, and growing consumer health consciousness to drive sales in India.
Nestlé Japan has announced plans to branch out from the food and beverage business into healthcare, with personalised nutrition and aged care a prominent feature of this shift.